As of 2026-10-22, the Relative Valuation of Regeneron Pharmaceuticals Inc (REGN) is 1,014.20 USD. This relative valuation is based on P/E multiples. With the latest stock price at 805.67 USD, the upside of Regeneron Pharmaceuticals Inc based on Relative Valuation is 25.9%.
The range of the Relative Valuation is 758.06 - 1,689.75 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.4x - 19.1x | 18.7x |
| Forward P/E multiples | 19.1x - 33.8x | 25.1x |
| Fair Price | 758.06 - 1,689.75 | 1,014.20 |
| Upside | -5.9% - 109.7% | 25.9% |
| Date | P/E |
| 2026-10-21 | 19.51 |
| 2026-10-20 | 19.56 |
| 2026-10-19 | 18.94 |
| 2026-10-16 | 19.15 |
| 2026-10-15 | 19.29 |
| 2026-10-14 | 18.85 |
| 2026-10-13 | 18.24 |
| 2026-10-12 | 18.48 |
| 2026-10-09 | 18.08 |
| 2026-10-08 | 17.91 |
| 2026-10-07 | 17.97 |
| 2026-10-06 | 17.89 |
| 2026-10-05 | 17.59 |
| 2026-10-02 | 17.81 |
| 2026-10-01 | 17.80 |
| 2026-09-30 | 18.37 |
| 2026-09-29 | 18.18 |
| 2026-09-28 | 18.22 |
| 2026-09-25 | 19.09 |
| 2026-09-24 | 19.28 |
| 2026-09-23 | 19.42 |
| 2026-09-22 | 19.47 |
| 2026-09-21 | 19.33 |
| 2026-09-18 | 19.01 |
| 2026-09-17 | 19.12 |
| 2026-09-16 | 18.76 |
| 2026-09-15 | 18.75 |
| 2026-09-14 | 19.22 |
| 2026-09-11 | 18.93 |
| 2026-09-10 | 19.21 |
| 2026-09-09 | 19.56 |
| 2026-09-08 | 19.63 |
| 2026-09-04 | 20.05 |
| 2026-09-03 | 20.43 |
| 2026-09-02 | 20.64 |
| 2026-09-01 | 19.95 |
| 2026-08-31 | 19.35 |
| 2026-08-28 | 19.24 |
| 2026-08-27 | 19.56 |
| 2026-08-26 | 19.73 |
| 2026-08-25 | 20.19 |
| 2026-08-24 | 20.07 |
| 2026-08-21 | 20.20 |
| 2026-08-20 | 20.02 |
| 2026-08-19 | 20.36 |
| 2026-08-18 | 19.62 |
| 2026-08-17 | 19.52 |
| 2026-08-14 | 19.46 |
| 2026-08-13 | 19.52 |
| 2026-08-12 | 19.33 |